Nephro Care IPO

Nephro Care India Ltd

₹1,36,000 /1600 sharesMinimum Investment

Nephro Care IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
--₹90.00₹171.00₹81.00 (90.00%)

Nephro Care IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
28 Jun ‘24 - 2 Jul ‘24₹1,36,0001,600₹85 - ₹90
Issue SizeIPO Doc
41.26Cr
RHP PDF

About the company

Nephro Care India, founded in 2014 in Kolkata, offers medical services for renal patients. It is a treatment centre for clinical and lifestyle solutions for renal insufficiency. The treatment framework covers lifestyle, physiological, and spiritual wellness. The clinics use advanced technologies and diagnostic instruments. Currently, Nephro Care serves approximately 900 chronic kidney disease (CKD) patients every month. The team consists of about five permanent doctors, 10 visiting consultants, and 70 experienced paramedical professionals at the flagship clinic at Salt Lake.;
Founded in
2014
Managing director
Dr. Pratim Sengupta
Parent organisation
Nephro Care India Ltd

Strength and risks

Strengths
Risks
The company has developed in-house technology to produce dialysis-ready water from tap water using a portable RO system, which can be installed anywhere near a water supply. This RO system is being commercialised, and several units have been deployed for "Home Dialysis."
Their Telemedicine app allows patients to access telemedicine services via video, phone, or chat. Developed in-house, the app is currently in beta testing. The average monthly consultations through the app in Kolkata increased by 262.38%, from Rs 0.02 crore in fiscal 2022 to Rs 0.07 crore in fiscal 2023 to Rs 0.24 crore in the nine months ending December 31, 2023.
Each clinic operates on a ‘hub-and-spoke’ model, independently equipped with skilled healthcare professionals and advanced infrastructure to meet patients' healthcare needs and ensure their rehabilitation.
The company serves about 900 CKD patients per month. The income generated from healthcare services has increased steadily from Rs 1.82 crore in 2021 to Rs 3.42 crore in 2022, Rs 17.09 crore in 2023, and Rs 19.75 crore in the nine months ending December 31, 2023.
The company recently signed an agreement to lease a 60-bed hospital in Madhyamgram, Kolkata, and is converting it into a 100-bed multi-speciality hospital.

Financials

*All values are in Rs. Cr
No Graph Data To Display

Application details

Apply asPrice bandApply upto
Regular85 - 90₹2 Lakh
High Networth Individual85 - 90₹2 - 5 Lakh
For Nephro Care IPO, eligible investors can apply as Regular.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW